Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Frequency of treatment is determined by the dermatologist, usually starting at three times a week and then decreasing to once a week
Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom
Experimental study on humans
Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) $73.00 Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) is a premium multi-peptide research formulation designed for scientific studies involving growth hormone signaling pathways, peptide synergy investigations, metabolic research, and endocrine biology
| 09 2021
US$ 28.70
US$ 25.37
US$ 28.28
US$ 27.84
US$ 21.83
US$ 28.68
